Advion BioSciences, Inc. Opens Immunoassay Laboratory
June 21, 2007 — ITHACA, N.Y., June 21, 2007 – Advion BioSciences,Inc., through its BioServices subsidiary, will begin offering bioanalytical immunochemistry services to the pharmaceutical and biotechnology industry starting July, 2007. This business will allow Advion to provide critical discovery and development large molecule services to the fast growing macromolecule drug pipelines underway throughout the industry. Leading the scientific team will be Dr. Esme Farley and Byron Simpson, two highly respected immunochemists with decades of combined experience in the immunoassay field and extensive knowledge with regulated bioanalysis. The facility will be located in Manassas, Virginia, a suburb of Washington, DC.
According to David Patteson, President and CEO of Advion BioSciences, “It has long been a desire to offer our clients these services and we are very pleased to have such skilled immunologists join our team”. Suburban DC was chosen as the site for this lab due to the abundance of skilled scientists in the Virginia and Maryland area, and the availability of excellent pre-existing laboratory space. Tom Kurz, President of Advion BioServices went on to state: The immunoassay service is a nice complement to our LC/MS/MS services and allows us to fully serve the bioanalytical needs for both small molecule drugs and biologics. Consistent with Advion’s reputation for scientific excellence and unparalleled service, we are committed to building an exceptional immunoassay service laboratory.
In this new laboratory, Advion will provide a full range of ligand binding assays for the development and validation of traditional and custom designed ELISA’s, RIA’s, immunoassays, immunogenicity tests, multiplexed biomarker assays, cell based assays, and flow cytometry. Immunoassay services in support of development programs will be conducted under GLP conditions with the support of Advion’s existing infrastructure. All of Advion’s pre-existing quality and regulatory processes will be implemented at this facility.
About Advion:
Founded in 1993, Advion BioSciences, Inc. is an established leader in bioanalytical science and regulatory compliance and an innovator of products for the life science industry. More information about the company can be found on its website www.advion.com.
For Advion:
Amy Boardman
Manager of Corporate Marketing Communications
Advion BioSciences, Inc.
607.266.0665 ext. 314
aboardman@advion.com